Recombinant collagenase - Connext
Alternative Names: CNT-201; CNT-202Latest Information Update: 28 Apr 2026
At a glance
- Originator Connext
- Class Collagenases; Recombinant proteins; Skin disorder therapies
- Mechanism of Action Collagenase replacements
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Cellulite; Dupuytren's contracture; Peyronie's disease; Wounds
Highest Development Phases
- Phase I/II Dupuytren's contracture
- No development reported Cellulite; Peyronie's disease; Wounds
Most Recent Events
- 28 Apr 2026 No recent reports of development identified for preclinical development in Cellulite in South Korea (Parenteral)
- 28 Apr 2026 No recent reports of development identified for preclinical development in Peyronie's-disease in South Korea (Parenteral)
- 28 Apr 2026 No recent reports of development identified for preclinical development in Wounds in South Korea (Parenteral)